Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

Savara Inc. Highlights Long-Term IMPALA-2 Phase 3 Data for Molgramostim in aPAP

  • The Pharma Data
  • May 20, 2026

Savara Inc. Reports Sustained Efficacy and Favorable Safety Findings from the Ongoing IMPALA-2 Phase 3 Open-Label Extension Study of Molgramostim in aPAP Patients Savara Inc. announced the presentation of new…

Read MoreSavara Inc. Highlights Long-Term IMPALA-2 Phase 3 Data for Molgramostim in aPAP
  • Research

SERI Lugano Launches Global Scientific Initiative Focused on Light-Based Neuroscience and Pineal Gland Research

  • The Pharma Data
  • May 20, 2026

SERI Lugano Introduces Global Scientific Outreach Program Focused on Light-Based Neuroscience and Pineal Gland Research Switzerland Eye Research Institute, also known as SERI Lugano, has announced the launch of a…

Read MoreSERI Lugano Launches Global Scientific Initiative Focused on Light-Based Neuroscience and Pineal Gland Research
  • News

Texas Cancer Institute Adopts Kallisio Technologies Stentra™ as Standard Oral Immobilization Solution

  • The Pharma Data
  • May 20, 2026

Texas Cancer Institute Implements Kallisio Technologies Stentra™ as Standard-of-Care for Precision Radiation Therapy After Successful Clinical Pilot Kallisio announced that the Texas Cancer Institute has officially transitioned its use of…

Read MoreTexas Cancer Institute Adopts Kallisio Technologies Stentra™ as Standard Oral Immobilization Solution
  • Regulatory

Sensome Reports Positive First-in-Human Results for In Situ Lung Cancer Tumor Detection Technology

  • The Pharma Data
  • May 20, 2026

Sensome Reports Encouraging First-in-Human Clinical Results for Its Innovative In Situ Lung Tumor Detection Technology Sensome has announced positive results from its first-in-human INSPECT clinical study evaluating the company’s microsensor-enabled…

Read MoreSensome Reports Positive First-in-Human Results for In Situ Lung Cancer Tumor Detection Technology
  • Research

Portal Innovations and NJDEVCO Launch Johnson & Johnson Exchange at HELIX

  • The Pharma Data
  • May 20, 2026

Portal Innovations and New Brunswick Development Corporation Partner with Johnson & Johnson to Launch the Johnson & Johnson Exchange at the New Jersey Innovation Hub in HELIX, Strengthening New Jersey’s…

Read MorePortal Innovations and NJDEVCO Launch Johnson & Johnson Exchange at HELIX
  • Press Releases

Cosette Pharmaceuticals Names David Bell Chief Commercial Officer for Brands Division

  • The Pharma Data
  • May 20, 2026

Cosette Pharmaceuticals Enhances Commercial Leadership With Addition of Industry Veteran David Bell Cosette Pharmaceuticals has announced the appointment of David Bell as Chief Commercial Officer for its branded business, marking…

Read MoreCosette Pharmaceuticals Names David Bell Chief Commercial Officer for Brands Division
  • Regulatory

ForePass Demonstrates Bariatric Surgery-Like Benefits While Surpassing Leading GLP-1 Therapies

  • The Pharma Data
  • May 20, 2026

ForePass Shows Surgery-Like Benefits While Advancing a Less Invasive Approach to Obesity Treatment Keyron has announced the publication of new preclinical research in Gut, one of the world’s highest-ranked gastroenterology…

Read MoreForePass Demonstrates Bariatric Surgery-Like Benefits While Surpassing Leading GLP-1 Therapies
  • Press Releases

Sustained Therapeutics Showcases Positive Phase 2 ST-01 Results at AUA 2026 Annual Meeting

  • The Pharma Data
  • May 20, 2026

Sustained Therapeutics Highlights Positive Mid-Stage Clinical Outcomes for Its Investigational Therapy ST-01 Sustained Therapeutics has reported additional positive findings from its Phase 2 clinical study evaluating ST-01, the company’s proprietary…

Read MoreSustained Therapeutics Showcases Positive Phase 2 ST-01 Results at AUA 2026 Annual Meeting
  • News

Atrandi Biosciences Strengthens Leadership Team to Drive Global Growth of Capsule-Based Single-Cell Technologies

  • The Pharma Data
  • May 20, 2026

Atrandi Biosciences Enhances Executive Team to Drive International Growth of Its Innovative Single-Cell Technology Atrandi Biosciences has expanded its executive and governance leadership team with the appointment of Sam Ropp…

Read MoreAtrandi Biosciences Strengthens Leadership Team to Drive Global Growth of Capsule-Based Single-Cell Technologies
  • Regulatory

JCR Pharmaceuticals Showcases Promising CNS Gene Therapy Data at ASGCT 2026

  • The Pharma Data
  • May 19, 2026

JCR Pharmaceuticals Showcases Preclinical Gene Therapy Findings Demonstrating Strong CNS Uptake at the American Society of Gene and Cell Therapy 29th Annual Meeting JCR Pharmaceuticals presented new preclinical findings highlighting…

Read MoreJCR Pharmaceuticals Showcases Promising CNS Gene Therapy Data at ASGCT 2026
  • Research

AeroRx Therapeutics Reports Positive Phase 2a Results for Inhaled AERO-007 in COPD

  • The Pharma Data
  • May 19, 2026

AeroRx Therapeutics Reports Positive Phase 2a Results for Inhaled AERO-007 in COPD as First Nebulized LABA/LAMA Combination Candidate AeroRx Therapeutics has reported positive Phase 2a clinical data for AERO-007, an…

Read MoreAeroRx Therapeutics Reports Positive Phase 2a Results for Inhaled AERO-007 in COPD
  • Press Releases

Sumitomo Pharma America Presents AUA 2026 Data on Vibegron in Older Men With OAB and BPH

  • The Pharma Data
  • May 19, 2026

Sumitomo Pharma America Presents AUA 2026 Data Showing Vibegron Benefits in Older Men With Overactive Bladder and BPH Sumitomo Pharma America presented new clinical and real-world evidence from its urology…

Read MoreSumitomo Pharma America Presents AUA 2026 Data on Vibegron in Older Men With OAB and BPH
Next
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Savara Inc. Highlights Long-Term IMPALA-2 Phase 3 Data for Molgramostim in aPAP
  • SERI Lugano Launches Global Scientific Initiative Focused on Light-Based Neuroscience and Pineal Gland Research
  • Texas Cancer Institute Adopts Kallisio Technologies Stentra™ as Standard Oral Immobilization Solution
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.